ceprotin
takeda manufacturing austria ag - human protein c - purpura fulminans; protein c deficiency - antithrombotic agents - ceprotin is indicated for prophylaxis and treatment of purpura fulminans coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.
ceprotin 500unit powder and solvent for solution for injection vials
baxalta uk ltd - protein c - powder and solvent for solution for injection - 500unit
ceprotin 1000unit powder and solvent for solution for injection vials
baxalta uk ltd - protein c - powder and solvent for solution for injection - 1000unit
albiomin 20 %
kamada ltd, israel - plasma protein fraction - solution for infusion - plasma protein fraction 200 mg/ml - protein c - protein c - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendation.
ceprotin 1000 iu powder for solution for injection or infusion powder for solution for injection/infusion
baxter ag - austria, austria - protein c - powder for solution for injection/infusion - 1000 iu
ceprotin 500 iu powder for solution for injection or infusion
takeda manufacturing ag, austria - protein c - powder for solution for injection or infusion - 500 iu
ceprotin 500 iu powder for solution for injection or infusion powder for solution for injection/infusion
takeda manufacturing ag, austria - protein c - powder for solution for injection/infusion - 500 iu